AHL
CHE icon

Abel Hall LLC’s Chemed CHE Stock Holding History

Abel Hall LLC’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-677
Closed -$290K – 843
2025
Q4 		$290K Buy
+677
New +$295K 0.07% 348

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Abel Hall LLC's CHE Position: Q1 2026 in Review

Abel Hall LLC sold out of Chemed (CHE) in Q1 2026, closing a stake of 677 shares — an estimated $290K sold.

Abel Hall LLC first reported a position in CHE in Q4 2025 and held it in 1 quarter. The position peaked at $290K in Q4 2025. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Abel Hall LLC reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 677 Chemed shares in Q1 2026, an estimated $290K.
  • Abel Hall LLC first reported a position in Chemed in Q4 2025 and held it in 1 quarter.
  • Abel Hall LLC's Chemed position peaked at $290K in Q4 2025.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.